Last Update: Wednesday, July 23, 2014

LIFELONG HEALTH- Study: Mammograms a So-So Screening Tool PDF Print E-mail
Written by Dr. David Lipschitz   
Thursday, 20 December 2012 05:04

In a study published in the New England Journal of Medicine, researchers compared the rates of breast cancer before and after screening mammograms became widely available.

They found that instituting screening mammograms increased the diagnosis of very small breast cancers by more than 100 percent, from 112 cases per 100,000 women in 1976 to 234 per 100,000 in 2008. While tiny tumor diagnoses increased, mammograms did not reduce the rate of diagnosis of late-stage disease.

Over the 30-year period of study, the number of late-stage, larger cancers with a higher risk of mortality identified by mammography decreased by only 8 percent, from 109 to 94 cases per 100,000 women.

If mammography is a successful screening tool, it should detect the earliest cancers and, over time, this should be accompanied by at least as great a reduction of the larger, more advanced and dangerous tumors.

According to the authors of this study, Dr. A. Bleier and Dr. H.G. Welch, the fact that this did not occur implies that most of the early cancers were of no clinical significance, would not prove fatal and must have spontaneously resolved.

Based on these facts, they state that an estimated 1.3 million breast cancers were overdiagnosed during the 30-year period of this study and furthermore, that in 2008, breast cancers were over-diagnosed and unnecessarily treated in 70,000 women — or 31 percent of all new cancers diagnosed. Because mammograms have not reduced the rate at which more advanced cancers are diagnosed, they argue that mammograms are having only a small effect on the rate of deaths from breast cancer.

The conundrum clinicians face, however, is that, to date, no one can distinguish a small and harmless cancer from a small but potentially fatal cancer. In this report the authors note that in women over the age of 50, deaths from breast cancer during the period of this study decreased by 28 percent.

Until now, reduction of deaths was believed to reflect a combination of early detection by mammograms and better and more effective treatments.

Proponents of mammograms suggest that they contribute anywhere from 28 percent to 68 percent of the reduction in mortality.

Bleier and Welch suggest that most of the decrease in deaths comes from better treatment. To cement their argument, they note that women diagnosed with breast cancer between the ages of 40 and 50 — none of whom had a mammogram during this study period — had the greatest improvement in outcomes, with a reduction in deaths from breast cancer of 42 percent. This benefit could only be ascribed to better treatment.

Everyone agrees that mammograms do save lives. The question is: How many? Today, mammograms as a screening tool for breast cancer are an integral, deeply embedded component of the way in which we manage the health of adult women with a goal of early detection of breast cancer. To stop screening mammograms is unthinkable.

But we should certainly pay more attention to the age at which mammograms should be done and how frequently they are done. These parameters are critical because of the downsides of mammograms, which not only include the problem of identifying cancers of no clinical significance but also the socalled "false positive" where something suspicious on a mammogram leads to needless biopsies and even surgery.

There is still consensus that mammograms should commence at age 50 and end at age 75. If a person has no family history of breast cancer, has not used hormone replacement, does not smoke, has had children and has breastfed, a mammogram should be done every two to three years.

In Europe, every three years is frequently the norm. Any woman who has a strong family history of breast cancer, particularly if the cancer occurred at a young age, should get an annual mammogram. And based on a careful discussion between doctor and patient, the first mammogram can be recommended at age 40. The good news is that breast cancer treatments, even for cancers that have spread to lymph nodes, have a cure rate as high as 85 percent.

The key challenge with mammography at the moment is distinguishing between tiny cancers that will never cause a problem and those that will prove fatal without treatment. Until this differentiation can be made, we have no choice but to assume that all are potentially fatal and treat accordingly.

Dr. David Lipschitz is the author of the book "Breaking the Rules of Aging." To find out more about Dr. David Lipschitz visit

Last Updated on Thursday, 20 December 2012 05:10

Team members care for thousands of the region's sickest children with heart conditions, including fetuses, newborns, infants, children, adolescents, and adult, long-term patients with pediatric cardiovascular conditions. At Children's families experience coordinated, next-generation care, delivered by a compassionate, multidisciplinary team of leaders in the pediatric cardiology field. One of the largest pediatric cardiovascular programs in the region. Studies have shown that high volumes are associated with high quality and better outcomes, because experience is a major factor in quality of care. Wort was traditionally prescribed in parts of Europe for depression (in addition to use as a general-purpose tea), and Chinese medicine developed elaborate lists of herbs and preparations. With the scientific revolution in Europe and the United States, the use of traditional herbal remedies fell out of favor with the mainstream medical establishment, although a few people continued to use and maintain knowledge of traditional European herblore. In the early 20th century, scientists began reassessing this rejection of traditional herbs in medicine. Vorzüge eines intakten und lebendigen Gemeinschaftslebens bewahren. Dafür sorgen nicht zuletzt gut 120 lokale Vereine. Als wichtiger Faktor im Kulturleben haben sich die zahlreichen Museen und einige Kunstgalerien erwiesen. Descriptive and quantitative transcriptome analyses are important for interpreting the functional elements of the genome and revealing the molecular constituents of cells and tissues. It is known that sperm function can be affected by ASG proteins, including the processes of capacitation and the acrosome reaction, as well as canadian pharmacy accutane sperm motility, DNA integrity and interaction with the oocyte. BSPs (bovine seminal plasma protein, unigene 64,588 and unigene 69,768), fertilin (unigene 17,270 and unigene 27,136), ACE (Angiotensin converting enzyme, unigene 7,164 and unigene 21,069), GPX5 (glutathione peroxidase, epididymal secretory glutathione peroxidase, unigene15860), Spermadhesin-1 (Acidic seminal fluid protein, aSFP). The reproduction-related transcripts identified in the ASG and testis transcritptomes in E. This interaction of PDC-109 with the sperm cell membrane results in an efflux of cholesterol and choline phospholipids, that appears to be important for capacitation. The main changes in spermatozoa that occur during epididymal maturation are the ability to move, recognize and bind to the ZP, and to fuse with the plasma membrane of the oocyte.. Oct 2004, Adelaide, Australia. Ziaian T, Augostinos, M. Relationship Between Acculturation and Mental Well-being Among Young Persian Women Living in Australia. Paper presented at the Educational Research conference, 18th November 2004, Adelaide, Australia. Ziaian T, Stress Management: an introduction of holistic coping strategies. A Four day Course for the higher degree students. Targeted molecular therapy for advanced epithelial ovarian cancer. Minimally invasive surgery for gynecological cancer. Pharmaceutical Sciences from Shizuoka College of Pharmacy (1976, Japan). He has completed his B. Prophylactic removal of nevi without clinically worrisome characteristics is not recommended. The reasons for this are practical: many individuals in these families have a large number of nevi, and complete removal of them all is not feasible, since new atypical nevi continue to develop. In addition, individuals with increased susceptibility to melanoma may have cancer arise de novo, without a precursor lesion such as a nevus. The disadvantages of screening include the limitations of available noninvasive testing methods and the risks associated with invasive screening procedures. ERCP is the gold standard for identifying early cancers and precancerous lesions in the pancreas..